Earnings Summary: Ocugen Reports Q4 Results and Advances Gene Therapy Pipeline
Financial Performance For the fourth quarter of 2025, Ocugen reported a net loss of $17.7 million, or $0.06 per share,...
6 articles, transcripts, and reports
Financial Performance For the fourth quarter of 2025, Ocugen reported a net loss of $17.7 million, or $0.06 per share,...
Ocugen Inc (NASDAQ: OCGN) Q2 2022 Earnings Conference
Ocugen Inc (NASDAQ: OCGN) Q4 2021 Earnings Conference
Ocugen Inc (NASDAQ: OCGN) Q3 2021 Earnings Conference
Ocugen, inc (NASDAQ: OCGN) Q2 2021 Earnings Conference
Ocugen, Inc. (NASDAQ: OCGN) reported a wider loss in fiscal 2019 due to expenses related to the change in fair value of derivative liabilities, amidst…